I updated my table related to equity and value for LDX.
Note that the shares on issue might be a little off as I believe it to be around 422m, but I used previously shown shares on issue plus the recent raise shares placed. Please let me know if the figures are way off and I will correct it.
As a rough calculation LDX shareholder equity value i.e. if the company was liquidated today the value would be around 7c, before considering the added value of products and potential future earnings.
Taking into consideration that just last financial year LDX spent $42.8m to progress research and development with the major result of a new FDA approved test device, along with other products that generate income with increasing revenue and more balance spending, LDX for $22m current SP with $8m in cash ($6m after debt pay off) seems a joke.
It looks like it could be a turnaround point for the company and hopefully long term holders will start to see some return in the future.
GLTAH
LDX Price at posting:
5.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)